BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2205356)

  • 1. Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas.
    Kros JM; Van Eden CG; Stefanko SZ; Waayer-Van Batenburg M; van der Kwast TH
    Cancer; 1990 Sep; 66(6):1204-12. PubMed ID: 2205356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural characterization of transitional cells in oligodendrogliomas.
    Kros JM; de Jong AA; van der Kwast TH
    J Neuropathol Exp Neurol; 1992 Mar; 51(2):186-93. PubMed ID: 1538242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma.
    Herpers MJ; Budka H
    Acta Neuropathol; 1984; 64(4):265-72. PubMed ID: 6391068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation of gemistocytic cells and glial fibrillary acidic protein (GFAP)-positive oligodendroglial cells in gliomas: a MIB-1/GFAP double labeling study.
    Kros JM; Schouten WC; Janssen PJ; van der Kwast TH
    Acta Neuropathol; 1996; 91(1):99-103. PubMed ID: 8773153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic characteristics of GFAP-immunopositive oligodendroglial tumours Part I: immunohistochemical study.
    Matyja E; Taraszewska A; Zabek M
    Folia Neuropathol; 2001; 39(1):19-26. PubMed ID: 11678347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial fibrillary acidic protein (GFAP) in oligodendrogliomas: a reflection of transient GFAP expression by immature oligodendroglia.
    Jagadha V; Halliday WC; Becker LE
    Can J Neurol Sci; 1986 Nov; 13(4):307-11. PubMed ID: 3536047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendroglial tumors. An immunohistochemical and electron microscopic study.
    Sarkar C; Roy S; Tandon PN
    Cancer; 1988 May; 61(9):1862-6. PubMed ID: 3355979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MBP and GFAP immunohistochemistry of oligodendrogliomas with relationship to myelin-forming glia in cell differentiation].
    Hokama Y; Tanaka J; Nakamura H; Hori T
    No To Shinkei; 1986 Apr; 38(4):379-86. PubMed ID: 2424482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uniform lineage of oligodendrogliomas.
    de la Monte SM
    Am J Pathol; 1989 Sep; 135(3):529-40. PubMed ID: 2675625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological study of oligodendroglioma with special reference to immunohistochemical investigation].
    Kubo O; Tajika Y; Toyama T; Tajika T; Sakairi M; Katahira M; Kitamura K
    No Shinkei Geka; 1988 Aug; 16(9):1029-35. PubMed ID: 2462693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
    Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C
    Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphology of early stages of ENU-induced brain tumors in rats.
    Mennel HD; Simon H
    Exp Pathol; 1985; 28(4):207-14. PubMed ID: 3913606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell proliferation and glial fibrillary acidic protein in brain tumors].
    Kunz J; Gottschalk J; Jänisch W; Schulz W
    Acta Histochem; 1986; 80(1):53-61. PubMed ID: 3099535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GFAP in brain tumor diagnosis: possibilities and limitations.
    Gullotta F; Schindler F; Schmutzler R; Weeks-Seifert A
    Pathol Res Pract; 1985 Jul; 180(1):54-60. PubMed ID: 4034433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GFAP-positive neoplastic astrocytes in spontaneous oligodendrogliomas and mixed gliomas of rats.
    Nagatani M; Yamakawa S; Saito T; Ando R; Hoshiya T; Tamura K; Uchida K
    Toxicol Pathol; 2013; 41(4):653-61. PubMed ID: 23076037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
    Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
    Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural and immunohistochemical segregation of gemistocytic subsets.
    Kros JM; Stefanko SZ; de Jong AA; van Vroonhoven CC; van der Heul RO; van der Kwast TH
    Hum Pathol; 1991 Jan; 22(1):33-40. PubMed ID: 1985075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
    Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
    Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granular cells in oligodendroglioma suggest a neoplastic change rather than a reactive phenomenon: case report with molecular characterisation.
    Rao S; Sravya P; Chandran C; Saini J; Somanna S; Santosh V
    Brain Tumor Pathol; 2017 Jan; 34(1):42-47. PubMed ID: 27738816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic characteristics of GFAP-positive oligodendroglial tumours. Part II: ultrastructural study.
    Matyja E; Taraszewska A; Nagańska E; Zabek M
    Folia Neuropathol; 2001; 39(2):103-10. PubMed ID: 11680631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.